You are here

Clinical Trials: Liver Disease

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Wednesday, November 9, 2016 - 20:00
Condition:   Alcoholic Hepatitis
Interventions:   Drug: standard medical therapy;   Drug: G-CSF;   Drug: n-Acetylcysteine
Sponsor:   Postgraduate Institute of Medical Education and Research
Recruiting - verified November 2016
Posted: Friday, May 27, 2016 - 19:00
Condition:   Liver Failure
Intervention:   Drug: umbilical cord blood mesenchymal stem cells
Sponsor:   Sun Yat-sen University
Not yet recruiting - verified June 2016
Posted: Wednesday, May 25, 2016 - 19:00
Condition:   Decompensated Cirrhosis
Interventions:   Biological: Conventional therapy;   Biological: Injectable Collagen Scaffold + HUC-MSCs
Sponsors:   Chinese Academy of Sciences;   The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Recruiting - verified April 2016
Posted: Tuesday, March 8, 2016 - 20:00
Condition:   Acute on Chronic Hepatic Failure
Interventions:   Biological: Allogenic mesenchymal stem cells;   Other: Placebo
Sponsors:   Pere Gines;   Clinica Universidad de Navarra, Universidad de Navarra
Recruiting - verified August 2016
Posted: Monday, March 7, 2016 - 20:00
Condition:   Liver Cirrhosis
Intervention:   Biological: Mesenchymal Stem Cells
Sponsor:   Gulhane Military Medical Academy
Recruiting - verified March 2016
Posted: Thursday, January 7, 2016 - 20:00
Condition:   Hepatic Cirrhosis
Intervention:   Biological: Human umbilical cord mesenchymal stem cells
Sponsors:   Shenzhen Hornetcorn Bio-technology Company, LTD;   The Second Affiliated Hospital of University of South China
Not yet recruiting - verified January 2016
Posted: Wednesday, November 19, 2014 - 20:00
Condition:   Liver Cirrhosis
Intervention:   Drug: ADSCs
Sponsor:   Gwo Xi Stem Cell Applied Technology Co., Ltd.
Recruiting - verified February 2016
Posted: Monday, June 16, 2014 - 19:00
Conditions:   Chronic Hepatitis;   Hepatic Cirrhosis
Intervention:   Biological: Infusion of bone marrow mononuclear cells.
Sponsors:   Hospital Sao Rafael;   Ministry of Science and Technology, Brazil;   Ministry of Health, Brazil
Recruiting - verified April 2015
Posted: Monday, June 16, 2014 - 19:00
Condition:   End-stage Liver Disease
Intervention:   Drug: Autologous regulatory T cell product
Sponsors:   Guy's and St Thomas' NHS Foundation Trust;   King's College London
Recruiting - verified July 2014
Posted: Friday, December 20, 2013 - 20:00
Condition:   Hepatopulmonary Syndrome
Interventions:   Drug: Sorafenib;   Drug: Placebo
Sponsors:   University of Pennsylvania;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2016

Pages